Autopsy report · NCT00474552
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-315
Cause of deathNo reason given
Life of this trial
- Registered 1 month before it started.
- Ran for about 4 months before it stopped.
- 56 participants planned (an estimate, not an actual count).
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Sponsor type
- Industry
- Conditions
- Alzheimer Disease
- Interventions
- SAM-315
- Participants
- 56 (planned, not actual)
- Sites
- 1
- Countries
- France
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.